Auto Added by WPeMatico
On June 17, 2016, legislation was enacted to allow for safe and consistent access to medical assistance in dying for mentally competent adults who are suffering unbearably, are in an advanced state of irreversible decline, and whose natural deaths have become reasonably foreseeable.
A record number of Canadians have died from drug overdoses this year, including those involving fentanyl. Building on actions taken earlier this year, the Government of Canada is updating its drug strategy to provide for a comprehensive approach that will reduce the harms currently being experienced by individuals and communities.
The rapid rise in opioid-related overdose and death, exacerbated by the increased availability of illicit fentanyl across Canada, has highlighted gaps in the Government’s enforcement toolkit.
The Government of Canada is committed to a comprehensive, collaborative, compassionate and evidence-based approach to drug policy, which uses a public health approach when considering and addressing drug issues.
Many of the legislative amendments being proposed in Bill C-37 would modernize the Controlled Drugs and Substances Act (CDSA) to strengthen law enforcement and the Government’s ability to monitor, promote and enforce compliance.
Supervised consumption sites are an important harm reduction measure and part of a comprehensive, compassionate and evidence-based approach to drug policy.
The Honourable Jane Philpott, Federal Minister of Health and the Honourable Ralph Goodale, Minister of Public Safety and Emergency Preparedness, will make an important announcement regarding an Act to amend the Controlled Drugs and Substances Act and to make related amendments to other Acts.
I want to thank my co-host Minister Eric Hoskins for agreeing to help in the coordination of this very important day and for hosting it. And of course I want to also thank the folks at the Canadian Centre for Substance Abuse
OTTAWA – Shoppers Drug Mart, in consultation with Health Canada, is voluntarily recalling Life Brand Instant Read Digital Temple Thermometers (see photo below), Model No. 057800711568, due to some devices displaying temperatures that are lower than actual body temperatures. All affected devices were sold between January 2013 and December 2015.
November 30, 2016 (Ottawa, ON) – The Honourable Anne McLellan, Chair of the Task Force on Cannabis Legalization and Regulation, and Dr. Mark Ware, Vice Chair